Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025
-
Canada's growing tech industry and workforce highlighted in new CompTIA report
-
InspireMD Reports Second Quarter 2025 Financial Results
-
IMUNON Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Izotropic’s IzoView Positioned to Capitalize on Key Global Breast Imaging Market Drivers
-
CasinoTrac™ Continues Nevada Expansion
-
Magnite and REMAX Team Up to Power Commerce Media Expansion Across Onsite and Offsite Channels
-
Coralogix Becomes First Observability Vendor to Achieve ISO/IEC 42001:2023 Certification for Responsible AI Management
-
Veriff Recognized as Category Leader by Chartis Research in "Enterprise and Payment Fraud Solutions, 2025: Quadrant Update"
-
UPSTACK Acquires Pioneering Technology Consulting Agency Avail Partners
-
Element Fleet Management and Motus Announce Strategic Partnership to Deliver Comprehensive Mobility Solutions for All Drivers
-
Postino Elevates Hospitality Through Personalization With Bikky
-
Teledyne launches Z-Trak Express 1K5 for cost-effective, in-line 3D measurement and inspection
-
Tecan schedules conference call on August 12th to discuss half year 2025 financial results
-
Freshworks to Host Investor Day 2025 on September 11, 2025
-
BIO-key, Provider of Identity and Access Management Solutions with Enhanced Biometrics, Hosts Q2 Investor Call Wed. Aug. 13th at 10am ET
-
ModelOp Announces Strategic Partnership with Angularis.ai to Deliver Complete Enterprise AI Governance-as-a-Service Solution
-
Rackspace Technology Launches Cloud Management Platform with New Capabilities for Hybrid Environments
-
LYNO AI Reports Early Engagement in Presale with Over 100,000 Tokens Acquired
-
Smithfield’s “We Speak Pork” Campaign Features Pork So Good It Speaks for Itself
-
Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid
-
Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
-
StoneX Completes Acquisition of The Benchmark Company to Expand Investment Banking Capabilities
-
Amalgamated Bank Closes $1.7M Retroactive C-Pace Deal to Revitalize Nashville Retail Space
-
Hillman Reports Second Quarter 2025 Results
-
American Tungsten Strengthens Leadership Team to Drive Mining Operations Expansion
-
Surgery Partners, Inc. Announces Second Quarter 2025 Results
-
Knight Therapeutics Announces Regulatory Submission of CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Mexico
-
Humanoid Global Welcomes Dr. Ahad Armin to its Technical Advisory Committee
-
Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Altimmune to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025
-
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Flare Therapeutics Announces Initiation of Phase 1B Study of FX-909 for Treatment of Metastatic Urothelial Cancer
-
Creative Realities Deploys Digital Display Solution at Circle K Mexico to Drive Sales and Advance Sustainability Efforts
-
Prairie Operating Co. Announces Second Quarter 2025 Earnings Release Date and Conference Call
-
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025
-
Hillman’s Board of Directors Approves $100 Million Share Repurchase Program
-
Exodus Movement, Inc. July 2025 Treasury Update and Monthly Metrics
-
Judge Recognized by Staffing Industry Analysts on Multiple 2025 Industry Lists
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Neuronetics Reports Second Quarter 2025 Financial and Operating Results
-
Xometry Reports Record Second Quarter 2025 Results
-
Adaptec® SmartRAID 4300 Series of Accelerators Deliver Scalable, Secure NVMe® RAID Storage Solutions
-
Kaldalón hf.: Routine Announcement Regarding Share Buybacks Pursuant to Buyback Program
-
Forsys Announces Commencement of Expansion Drill Program at Namibplaas
-
SynOx Therapeutics Completes Enrollment in Registrational Phase 3 TANGENT Clinical Trial Significantly Ahead of Timeline
-
J & J Snack Foods Reports Fiscal 2025 Third Quarter Results
-
Ocular Therapeutix™ Reports Second Quarter 2025 Financial Results and Business Highlights
-
Enviri Corporation Reports Second Quarter 2025 Results
-
Sportradar Reports Second Quarter Financial Results and Raises Full Year 2025 Outlook
